Show simple item record

dc.contributor.authorSmuts, Corneliusen_US
dc.contributor.authorHon, G M
dc.contributor.authorHassan, M S
dc.contributor.authorVan Rensburg, S J
dc.contributor.authorAbel, S
dc.contributor.authorMarais, D W
dc.contributor.authorVan Jaarsveld, P
dc.contributor.authorHenning, F
dc.contributor.authorErasmus, R T
dc.contributor.authorMatsha, T
dc.identifier.citationSMUTS, C., HON, G.M., HASSAN, M.S., VAN RENSBURG, S.J., ABEL, S., MARAIS, D.W., VAN JAARVELD, P., HENNING, F., ERASMUS, R.T. & MATSHA, T. 2009. Erythrocyte membrane fatty acids in patients with multiple sclerosis. Multiple Sclerosis, 15(6):759-62, Jun. []en_US
dc.identifier.issn1477-0970 (Online)
dc.description.abstractBackground Reports on fatty acids levels in multiple sclerosis remain inconclusive. Objective To determine the erythrocyte membrane fatty acid levels in multiple sclerosis patients and correlate with Kurtzke Expanded Disability Status Scale. Methods Fatty acid composition of 31 multiple sclerosis and 30 control individuals were measured by gas chromatography. Results The membrane phosphatidylcholine C20:4n – 6 concentration was lower in the multiple sclerosis patients when compared to that of the control group, P = 0.04 and it correlated inversely with the EDSS and FSS. Conclusion Decrease in C20:4n – 6 in the erythrocyte membrane could be an indication of depleted plasma stores, and a eflection of disease severity. Multiple Sclerosis 2009; 15: 759–762.
dc.publisherSAGE Publications
dc.titleErythrocyte membrane fatty acids in patients with multiple sclerosisen_US

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record